These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15386662)

  • 1. Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models.
    Manca A; Rice N; Sculpher MJ; Briggs AH
    Health Econ; 2005 May; 14(5):471-85. PubMed ID: 15386662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modeling.
    Manca A; Lambert PC; Sculpher M; Rice N
    Med Decis Making; 2007; 27(4):471-90. PubMed ID: 17641141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility.
    Manca A; Hawkins N; Sculpher MJ
    Health Econ; 2005 May; 14(5):487-96. PubMed ID: 15497198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian modelling of healthcare resource use in multinational randomized clinical trials.
    Gauthier A; Manca A; Anton S
    Pharmacoeconomics; 2009; 27(12):1017-29. PubMed ID: 19908926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving costing methods in multicentre economic evaluation: the use of multiple imputation for unit costs.
    Grieve R; Cairns J; Thompson SG
    Health Econ; 2010 Aug; 19(8):939-54. PubMed ID: 19688811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A framework for cost-effectiveness analysis from clinical trial data.
    O'Hagan A; Stevens JW
    Health Econ; 2001 Jun; 10(4):303-15. PubMed ID: 11400253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
    Barbieri M; Drummond M; Willke R; Chancellor J; Jolain B; Towse A
    Value Health; 2005; 8(1):10-23. PubMed ID: 15841890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach.
    Ramsey SD; Blough DK; Sullivan SD
    Med Care; 2008 May; 46(5):542-8. PubMed ID: 18438203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mind the Gap! A Multilevel Analysis of Factors Related to Variation in Published Cost-Effectiveness Estimates within and between Countries.
    Boehler CE; Lord J
    Med Decis Making; 2016 Jan; 36(1):31-47. PubMed ID: 25878194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
    Ramsey SD; Willke RJ; Glick H; Reed SD; Augustovski F; Jonsson B; Briggs A; Sullivan SD
    Value Health; 2015 Mar; 18(2):161-72. PubMed ID: 25773551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of early treatment for retinopathy of prematurity.
    Kamholz KL; Cole CH; Gray JE; Zupancic JA
    Pediatrics; 2009 Jan; 123(1):262-9. PubMed ID: 19117891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.
    Willan AR; O'Brien BJ
    Health Econ; 1996; 5(4):297-305. PubMed ID: 8880166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian cost-effectiveness analysis from clinical trial data.
    O'Hagan A; Stevens JW; Montmartin J
    Stat Med; 2001 Mar; 20(5):733-53. PubMed ID: 11241573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of a multinational RCT with a binary measure of effectiveness and an interacting covariate.
    Willan AR; Kowgier ME
    Health Econ; 2008 Jul; 17(7):777-91. PubMed ID: 17764096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of costs and cost-effectiveness in multinational trials.
    Koopmanschap MA; Touw KC; Rutten FF
    Health Policy; 2001 Nov; 58(2):175-86. PubMed ID: 11551665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collecting and analysing cost data for complex public health trials: reflections on practice.
    Batura N; Pulkki-Brännström AM; Agrawal P; Bagra A; Haghparast-Bidgoli H; Bozzani F; Colbourn T; Greco G; Hossain T; Sinha R; Thapa B; Skordis-Worrall J
    Glob Health Action; 2014; 7():23257. PubMed ID: 24565214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.
    Oostenbrink JB; Rutten-van Mölken MP; Monz BU; FitzGerald JM
    Value Health; 2005; 8(1):32-46. PubMed ID: 15841892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results.
    Mantopoulos T; Mitchell PM; Welton NJ; McManus R; Andronis L
    Eur J Health Econ; 2016 Nov; 17(8):927-938. PubMed ID: 26445961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.